Mylanta recall adds to Johnson & Johnson woes
12 Variations of Mylanta and Alternagel Antacids Recalled for Not Posting Alcohol Content of Flavorings
Health care product giant Johnson & Johnson is adding to its growing list of recalls this year -- this time a dozen types of Mylanta and one Alternagel antacid.
The wholesale and retail level recall was not done because of "adverse effects," the company said, but because an internal review showed the bottles failed to note the alcohol content of some flavoring agents.
"Certain flavoring agents contribute small (less than 1 percent) amounts of alcohol," the company said on the Mylanta website. "It is unlikely that use of these products will cause either absorption or alcohol sensitivity related adverse events."
The recall announcement
"In consultation with the U.S. Food and Drug Administration (FDA), Johnson & Johnson-Merck Consumer Pharmaceuticals, Co. (JJMCP) is recalling, from the wholesale and retail level, twelve MYLANTA® liquid products and one AlternaGEL® liquid product. JJMCP is conducting the recall in order to update the labeling for these products. The specific products involved, listed below, are being recalled in the United States and Puerto Rico.
JJMCP initiated the recall after an internal review revealed that information about the presence of alcohol from flavoring agents was not noted on the packaging. Certain flavoring agents contribute small (< 1%) amounts of alcohol. It is unlikely that use of these products will cause either alcohol absorption or alcohol sensitivity related adverse events.
This is a wholesale and retail level recall and is not being undertaken on the basis of adverse events. No action is required by consumers or healthcare providers and consumers can continue to use the product".
The recall affects as many as 12 million bottles of Mylanta and 85,000 bottles of Alternagel, according to a Reuters report.
Johnson & Johnson advised that there was no consumer safety concern related to the recall, and the products can still be used as directed.
It is yet another blow to the company whose manufacturer has already made more than half a dozen recalls this year alone, including the largest recall in children's medicine history.
The recall affects as many as 12 million bottles of Mylanta and 85,000 bottles of Alternagel, according to a Reuter report.
Johnson & Johnson advised that there was no consumer safety concern related to the recall, and the products can still be used as directed.
It's yet another blow to the company whose manufacturer has already made more than half a dozen recalls this year alone, including the largest recall in children's medicine history.
Mylanta recall adds to Johnson & Johnson woes